The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York More Americans are injecting themselves with peptides fda warning bpc 157 peptide products New Details 157 When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA to Convene Pharmacy Compounding Advisory Committee in July